Literature DB >> 560153

Toxicologic and teratologic studies of oxibendazole in ruminants and laboratory animals.

V J Theodorides, C J DiCuollo, T Nawalinski, C R Miller, J R Murphy, J F Freeman, J C Killeen, W R Rapp.   

Abstract

Acute toxicity of oxibendazole was assessed with single oral doses given to mice (4 to 32 g/kg of body weight), sheep (230 to 600 mg/kg), and cattle (600 mg/kg); there were no ill effects. Subacute toxicity did not occur with multiple doses given 5 days to cattle (30 to 75 mg/kg/day) and to sheep (10 to 50 mg/kg/day). Chronic effects did not occur with daily doses of 3 to 30 mg/kg given 98 days to rats and dogs. Teratogenicity of the compound was studied in mice, rats, and sheep medicated at a dose level of 30 mg of oxibendazole/kg and in cattle given 75 mg/kg on selected dates during pregnancy. Microscopically, rodent fetuses seemed normal, and on gross physical examination, lambs and calves were free of malformations and ossification variations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 560153

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Some aspects of the teratogenicity of veterinary drugs.

Authors:  P Delatour
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

2.  Oxibendazole inhibits prostate cancer cell growth.

Authors:  Qiaoli Chen; Yuhua Li; Xiaoyu Zhou; Runsheng Li
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

Review 3.  The Antitumor Potentials of Benzimidazole Anthelmintics as Repurposing Drugs.

Authors:  Deok-Soo Son; Eun-Sook Lee; Samuel E Adunyah
Journal:  Immune Netw       Date:  2020-08-04       Impact factor: 6.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.